PPMI is an observational clinical study to verify progression markers in Parkinson’s disease. The study is designed to establish a comprehensive set of clinical, imaging and biosample data that will be used to define biomarkers of PD progression. Once these biomarkers are defined, they can be used in therapeutic studies. The clinical, imaging and biologic data are accessible to researchers in real time through the website.